Australia's top brokers have been busy adjusting their estimates and recommendations once again. This has led to the release of a number of broker notes.
Three broker buy ratings that have caught my eye are summarised below. Here's why brokers think these ASX shares are in the buy zone:
CSL Limited (ASX: CSL)
According to a note out of Macquarie, its analysts have retained their outperform rating and lifted their price target on this biotherapeutics company's shares to $312.00. The broker believes that CSL's new plasma collection platform could increase yields by 10% per donation in the future. It feels this could give its gross profit a big boost if regulatory approval is granted later this year or early in 2022. The CSL share price is trading at $278.51 on Thursday.
EML Payments Ltd (ASX: EML)
Another note out of Macquarie reveals that its analysts have retained their outperform rating but slashed the price target on this payments company's shares to $4.00. This follows news that the Central Bank of Ireland has concerns over its Prepaid Financial Services business, which could see its licence revoked. Macquarie has adjusted its valuation to account for the worst-case scenario. However, it is optimistic this will not happen. The EML Payments share price is recovering today but is still well below this price target at $3.18.
Webjet Limited (ASX: WEB)
Analysts at Credit Suisse have retained their outperform rating but trimmed their price target on this online travel agent's shares to $5.20. This follows the release of its full year results on Wednesday. According to the note, the broker has reduced its FY 2022 estimates to reflect a delay in international travel. However, it remains positive on the future and expects Webjet's earnings to grow strongly once the crisis passes. Particularly given pent-up demand and its stronger margins. The Webjet share price is fetching $4.51 this morning.
